Stay updated on AMG 820 and Pembrolizumab Combo in Solid Tumor Clinical Trial
Sign up to get notified when there's something new on the AMG 820 and Pembrolizumab Combo in Solid Tumor Clinical Trial page.

Latest updates to the AMG 820 and Pembrolizumab Combo in Solid Tumor Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page adds a new site revision label: v3.6.5, replacing the previous v3.6.4. This indicates a behind-the-scenes site update rather than a substantive change to study data or page content.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe page now shows Revision: v3.6.4, replacing the previous v3.6.3 tag, indicating a minor update to the page's revision history.SummaryDifference0.0%

- Check56 days agoChange DetectedThe page now shows an updated build revision (v3.6.3) replacing the previous v3.6.0, indicating a minor update to the page’s versioning.SummaryDifference0.0%

- Check70 days agoChange DetectedRecruitment status updated to 'No longer looking for participants', indicating enrollment has closed. New help and navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study), alongside a minor header formatting change (Intervention/Treatment) and a page revision tag (Revision: v3.6.0).SummaryDifference0.4%

- Check77 days agoChange DetectedThe page's revision label updated from v3.5.4 to v3.5.5, indicating a newer version of the page content. This is a metadata update rather than a substantive change to the information presented.SummaryDifference0.0%

- Check99 days agoChange DetectedA new revision label v3.5.4 appears on the page, replacing the previous v3.5.3 and signaling a newer page build. The update does not modify the study details or other visible content.SummaryDifference0.0%

Stay in the know with updates to AMG 820 and Pembrolizumab Combo in Solid Tumor Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AMG 820 and Pembrolizumab Combo in Solid Tumor Clinical Trial page.